186 related articles for article (PubMed ID: 25888627)
1. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.
Wang G; Song Y; Liu T; Wang C; Zhang Q; Liu F; Cai X; Miao Z; Xu H; Xu H; Cao L; Li F
Oncotarget; 2015; 6(12):9877-86. PubMed ID: 25888627
[TBL] [Abstract][Full Text] [Related]
2. By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.
Zhang Q; Song Y; Chen W; Wang X; Miao Z; Cao L; Li F; Wang G
Oncotarget; 2015 Jun; 6(18):16461-70. PubMed ID: 26098774
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1.
Liu F; Li X; Wang C; Cai X; Du Z; Xu H; Li F
Int J Cancer; 2009 Dec; 125(11):2511-9. PubMed ID: 19610058
[TBL] [Abstract][Full Text] [Related]
4. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response.
Li DQ; Nair SS; Ohshiro K; Kumar A; Nair VS; Pakala SB; Reddy SD; Gajula RP; Eswaran J; Aravind L; Kumar R
Cell Rep; 2012 Dec; 2(6):1657-69. PubMed ID: 23260667
[TBL] [Abstract][Full Text] [Related]
5. MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.
Pan Z; Ding Q; Guo Q; Guo Y; Wu L; Wu L; Tang M; Yu H; Zhou F
Int J Oncol; 2018 Jul; 53(1):59-72. PubMed ID: 29620211
[TBL] [Abstract][Full Text] [Related]
6. PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis.
Guo Q; Su N; Zhang J; Li X; Miao Z; Wang G; Cheng M; Xu H; Cao L; Li F
Oncogene; 2014 Jun; 33(25):3277-87. PubMed ID: 23893240
[TBL] [Abstract][Full Text] [Related]
7. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
8. P21-activated protein kinase 1 is overexpressed in gastric cancer and induces cancer metastasis.
Li LH; Luo Q; Zheng MH; Pan C; Wu GY; Lu YZ; Feng B; Chen XH; Liu BY
Oncol Rep; 2012 May; 27(5):1435-42. PubMed ID: 22293972
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.
Chung JH; Kim DH; Kim YS; Son BS; Kim D; Hwang C; Shin D; Noh SG; Han JH; Kim DK; Kim JH; Koo JS; Chung HY; Yoon SH
Cell Physiol Biochem; 2018; 50(1):304-316. PubMed ID: 30282071
[TBL] [Abstract][Full Text] [Related]
10. PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.
Wang G; Zhang Q; Song Y; Wang X; Guo Q; Zhang J; Li J; Han Y; Miao Z; Li F
Cell Death Dis; 2015 Mar; 6(3):e1682. PubMed ID: 25766321
[TBL] [Abstract][Full Text] [Related]
11. HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells.
Tong Y; Li Y; Gu H; Wang C; Liu F; Shao Y; Li F
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1104-1114. PubMed ID: 29339121
[TBL] [Abstract][Full Text] [Related]
12. MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation.
Liu J; Zhang Q; Ruan B; Chen W; Zheng J; Xu B; Jiang P; Miao Z; Li F; Guo JY; Cao L; Wang G
Cell Death Differ; 2019 Oct; 26(10):1905-1917. PubMed ID: 30644437
[TBL] [Abstract][Full Text] [Related]
13. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
14. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway.
Wang Z; Jia G; Li Y; Liu J; Luo J; Zhang J; Xu G; Chen G
Oncotarget; 2017 Apr; 8(14):22563-22580. PubMed ID: 28186966
[TBL] [Abstract][Full Text] [Related]
16. Aberrant high expression level of MORC2 is a common character in multiple cancers.
Ding QS; Zhang L; Wang BC; Zeng Z; Zou XQ; Cao PB; Zhou GM; Tang M; Wu L; Wu LL; Yu HG; Guo Y; Zhou FX
Hum Pathol; 2018 Jun; 76():58-67. PubMed ID: 29555576
[TBL] [Abstract][Full Text] [Related]
17. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.
Zhou Y; Zhang J; Wang J; Cheng MS; Zhao DM; Li F
Anat Rec (Hoboken); 2019 Sep; 302(9):1571-1579. PubMed ID: 30773850
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
19. Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents.
Hu SY; Qian JX; Yang SY; Andriani L; Liao L; Deng L; Huang MY; Zhang YL; Zhang FL; Shao ZM; Li DQ
Clin Transl Med; 2023 Mar; 13(3):e1210. PubMed ID: 36967563
[TBL] [Abstract][Full Text] [Related]
20. TAZ negatively regulates the novel tumor suppressor ANKRD52 and promotes PAK1 dephosphorylation in lung adenocarcinomas.
Lee TF; Liu YP; Lin YF; Hsu CF; Lin H; Chang WC; Pan CM; Chou TY; Wu CW
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118891. PubMed ID: 33096142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
